NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Eyenovia (EYEN), Inc. , an ophthalmic technology company, today announced the U.S. launch and commercial availability of clobetasol propionate ophthalmic ...
Eyenovia, Inc., an ophthalmic technology company, has announced it is consulting with Chardan as its financial advisor to explore various strategic alternatives, including potential business ...
Eyenovia announces progress on its user-filled Optejet eye drop dispenser, aiming for U.S. regulatory approval in late 2025. Eyenovia, Inc. has made significant advancements in the development of its ...
2022 FEB 08 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Investigators publish new report on Information Technology. According to news originating from ...
The Office of the National Coordinator for Health Information Technology has announced an Ocular Imaging Challenge, a call to developers to create an application that improves interoperability among ...
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol ® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet ® device platform ...
EMERYVILLE, Calif. & NEW YORK--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia, Inc. (NASDAQ ...
2023 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Current study results on Information Technology have been published. According to news reporting from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback